Cargando…
Pharmacologic Management of Persistent Pain in Cancer Survivors
Improvements in screening, diagnosis and treatment of cancer has seen cancer mortality substantially diminish in the past three decades. It is estimated there are almost 20 million cancer survivors in the USA alone, but some 40% live with chronic pain after completing treatment. While a broad defini...
Autores principales: | Glare, Paul, Aubrey, Karin, Gulati, Amitabh, Lee, Yi Ching, Moryl, Natalie, Overton, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888381/ https://www.ncbi.nlm.nih.gov/pubmed/35175587 http://dx.doi.org/10.1007/s40265-022-01675-6 |
Ejemplares similares
-
Psychosocial characteristics of chronic pain in cancer survivors referred to an Australian multidisciplinary pain clinic
por: Glare, Paul A., et al.
Publicado: (2022) -
Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study
por: Oh, Daniel, et al.
Publicado: (2021) -
Does transdermal fentanyl work in patients with low BMI? Patient‐reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl
por: Moryl, Natalie, et al.
Publicado: (2019) -
DEVELOPMENT OF AN OPIOID EDUCATION RESOURCE FOR OLDER CANCER PATIENTS
por: Manna, Ruth, et al.
Publicado: (2019) -
Factors That Predict Persistent Smoking of Cancer Survivors
por: Kim, Hyoeun, et al.
Publicado: (2015)